Getting ahead of colon cancer.
Through the use of new technology, AI Lumen is implementing innovative ways to discover cancerous polyps, effectively.
About AI Lumen
-
AI Lumen develops accessory devices which provide wireless, real-time near-high-definition images and video for endoscopic applications.
-
These systems wirelessly transmit images and video from within the human body, through tissue, and convert them to recognizable near-high-definition images using a proprietary super resolution artificial intelligence algorithm.
-
The company’s initial offering will be a wireless battery powered retroview (backward looking) cap for colonoscopies allowing gastroenterologists the ability to view behind haustral folds without retroflexing.
Colorectal Cancer (CRC)
-
Worldwide, colorectal cancer is the 3rd most diagnosed cancer and an estimated 1.9 million people were diagnosed in 2020 resulting in ~915 thousand deaths.
-
In the US, CRC is the 4th most common cancer and 4th most common cause of cancer deaths with~126,000 new cases diagnosed in 2020 (the latest year data is available) with ~52,000 deaths.
-
Patients diagnosed in early stages have a greater than ~90% survivability rate
-
More (button) (link to Colorectal Cancer CRC page)
Problem (iCRC and Hidden Polyps)
-
Interval Colorectal Cancer (iCRC) - 3%-8% of CRC patients had a colonoscopy 3-5 years prior to CRC diagnosis
-
Recent large sample studies have shown procedures and equipment currently utilized may miss 20%-25% of polyps using standard endoscopes
-
One reason for these misses is the difficulty in seeing behind haustral folds (~15% of mucosal area) when using the forward-looking camera of a standard colonoscope.
AI Lumen Solution
-
AI Lumen offers a wireless, retroview accessory device which allows gastroenterologists to see behind haustral folds.
-
As a scope-based accessory device, AI Lumen allows GIs to cost effectively upgrade their capabilities, to see behind tissue (haustral) folds, without changing their equipment.
-
This device will enable GIs to visualize a greater percentage of the mucosa than possible using only a forward-looking scope.
-
Greater visualization should increase adenoma detection rate (ADR) and reduce interval colorectal cancer (ICC).